Amber Implants, a medical technology company developing next generation spinal implants for spinal injuries, has closed a USD10 million Series A Financing which was co-led by the firm's founders and existing venture capital investors, with participation from angel investors and non-dilutive government funding.

Proceeds from the financing will be used to advance the Company’s revolutionary vertebral body augmentation system, VCFix®, through all preclinical verification and validation tests, ISO 13485 certification, regulatory activities, and an early feasibility clinical study and a pilot and pivotal clinical trial.